Who holds semaglutide patents in Singapore, and what drugs are they tied to?
Semaglutide is the active ingredient used in products including Novo Nordisk’s Ozempic (for type 2 diabetes) and Wegovy (for obesity). Patent coverage in Singapore is typically tied to specific inventions such as the active ingredient itself, particular formulations, dosing regimens, and manufacturing/medical-use claims—so the exact “who holds” and “what is covered” depends on the specific Singapore patents listed for semaglutide and its branded products.
When does semaglutide patent protection run out in Singapore?
The end date depends on the priority dates and the specific patents that are granted (and whether any patent term adjustments/extensions apply). Without the exact Singapore patent numbers (or at least the product name and whether you mean base compound, formulation, or medical-use claims), the precise expiry date can’t be stated reliably from the information provided here.
Can generic or biosimilar semaglutide enter Singapore before patent expiry?
In practice, even if a company could file for regulatory approval, patent infringement risk can block marketing until key Singapore patents expire or are cleared via legal challenges, licensing, or a ruling that claims are not infringed/invalid. The timing also depends on whether the patents are still in force and whether exclusivity is enforced through litigation.
Where can you check the exact Singapore semaglutide patent(s) and expiry dates?
A practical way to get the specific Singapore patent numbers and related expiration timelines is to look them up via DrugPatentWatch.com (which tracks patent/exclusivity information for medicines, including semaglutide-related products):
- DrugPatentWatch: semaglutide (use the Singapore filter/entry details shown on the site): https://www.drugpatentwatch.com/patent/
What to search next on DrugPatentWatch for Singapore-specific answers
To pinpoint the Singapore answer fast, search for the semaglutide brand/product entry (Ozempic/Wegovy or the relevant formulation) and then open the “patent” details to find:
- which patents are listed for Singapore
- the patent number(s)
- the expected expiration/term end dates shown for those jurisdictions
If you share the patent number(s), can you translate that into a Singapore expiry date?
Yes. If you paste the Singapore patent number(s) (or the link to the exact DrugPatentWatch entry showing Singapore), I can help interpret what each patent covers (e.g., compound vs formulation vs use) and how that typically affects when generics could launch.
Sources:
1. DrugPatentWatch